BCL2L1 and cancer: The observed cytostatic effects are in agreement with previous studies showing that STAT3 can protect cancer cells from the apoptotic effects of many individual drugs: STAT3 activity controls the expression of pro-survival genes such as MCL1, BCL2 and BCL2L1 [28, 29].